About

At Fraunhofer Center MEOS, scientists from three different Fraunhofer institutes work together on an interdisciplinary basis in the field of biomedicine. 

The Fraunhofer-Gesellschaft

The Fraunhofer-Gesellschaft based in Germany is the world’s leading applied research organization. Prioritizing key future-relevant technologies and commercializing its findings in business and industry, it plays a major role in the innovation process. A trailblazer and trendsetter in innovative developments and research excellence, it is helping shape our society and our future. Founded in 1949, the Fraunhofer-Gesellschaft currently operates 76 institutes and research units throughout Germany. 

Founding of Fraunhofer Center MEOS

Three of the 76 institutes came together in 2017 with the vision of bundling their key competencies in a project center that specializes in the research field of biomedicine. Specifically, microelectronic and optical systems for biomedicine are to be developed.

In October 2018, the starting signal was given for Fraunhofer Center MEOS and opened under the direction of Dr. Michael Scholles. Until the end of 2022, Fraunhofer MEOS will still be in the start-up phase and will receive equal start-up funding from the Freistaat Thüringen (Land of Thuringia) and the Fraunhofer-Gesellschaft.

In order to advance system development, Fraunhofer IPMS is working on M(O)EMS components and the associated signal processing. As a recognized competence center for optics and photonics, Fraunhofer IOF supplies the necessary optical concepts and components, system integration and image analysis. The third institute involved is Fraunhofer IZI, which brings the necessary expertise in biomedical applications, the associated specifications and requirements and also has the opportunity to carry out tests in the application environment.